Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...

Jameela Jamil has given her two cents on Serena Williams’ endorsement of the GLP-1 weight loss drug. On August 21, 2025, the ...

Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, ...

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

Older adults with diabetes using GLP-1 receptor agonist medications may face increased risk of serious eye conditions, study ...

Serena Williams sparked a heated debate after revealing she lost 31 pounds using a GLP-1 drug. While the tennis legend ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...